Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 6/20 | 0.31 |
| ▸ | CA2 | P00918 | 6/20 | 0.31 |
| ▸ | CA9 | Q16790 | 6/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7698937 | 0.94 | TSHR (0.38) | TSHRALDH1A1HPGD | |
| SCHEMBL7704153 | 0.86 | TSHR (0.32) | TSHR | |
| SCHEMBL776945 | 0.83 | EPHX2 (0.42) | TSHRHPGDCA1CA2CA9 | |
| SCHEMBL28888136 | 0.81 | EPHX2 (0.46) | TSHRHPGDCA1CA2CA9 | |
| SCHEMBL4304767 | 0.81 | EPHX2 (0.46) | TSHRHPGDCA1CA2CA9 | |
| SCHEMBL778726 | 0.81 | EPHX2 (0.46) | TSHRHPGDCA1CA2CA9 | |
| SCHEMBL4299797 | 0.81 | EPHX2 (0.46) | TSHRHPGDCA1CA2CA9 | |
| SCHEMBL28431774 | 0.81 | EPHX2 (0.46) | TSHRHPGDCA1CA2CA9 | |
| SCHEMBL28383874 | 0.81 | EPHX2 (0.46) | TSHRHPGDCA1CA2CA9 | |
| SCHEMBL9129611 | 0.81 | EPHX2 (0.46) | TSHRHPGDCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023229121-A1 | METHOD FOR PRODUCING HIGH-PURITY LITHIUM SULFIDE THROUGH WET AND DRY PROCESSES | 주식회사 정석케미칼 | 2023-11-30 | — | — | WO | claimed |
| US-20160354342-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACID-RELATED GASTROINTESTINAL DISORDERS CONTAINING A DITHIOLANE COMPOUND AND A GASTRIC ACID SECRETION INHIBITOR. | SHAHID MUSLIM D (US) | 2016-12-08 | — | — | US | claimed |
| US-6403256-B1 | Alkali metal electrochemical cell activated with a nonaqueous electrolyte having a sulfite additive | WILSON GREATBATCH LTD. | 2002-06-11 | — | — | US | claimed |
| US-6350542-B1 | Sulfite additives for nonaqueous electrolyte rechargeable cells | WILSON GREATBATCH LTD. | 2002-02-26 | — | — | US | claimed |
| EP-1022799-A2 | Sulfite additives for non-aqueous electrolyte rechargeable cells | Wilson Greatbatch Limited (US) | 2000-07-26 | — | — | EP | claimed |
| WO-2023229121-A1 | METHOD FOR PRODUCING HIGH-PURITY LITHIUM SULFIDE THROUGH WET AND DRY PROCESSES | 주식회사 정석케미칼 | 2023-11-30 | — | — | WO | disclosed |
| US-6403256-B1 | Alkali metal electrochemical cell activated with a nonaqueous electrolyte having a sulfite additive | WILSON GREATBATCH LTD. | 2002-06-11 | — | — | US | disclosed |
| US-6350542-B1 | Sulfite additives for nonaqueous electrolyte rechargeable cells | WILSON GREATBATCH LTD. | 2002-02-26 | — | — | US | disclosed |
| EP-1022799-A2 | Sulfite additives for non-aqueous electrolyte rechargeable cells | Wilson Greatbatch Limited (US) | 2000-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160354342-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACID-RELATED GASTROINTESTINAL DISORDERS CONTAINING A DITHIOLANE COMPOUND AND A GASTRIC ACID SECRETION INHIBITOR. | ALAD, ALOX15B, FABP6 | TSHR 1716/4885ALDH1A1 692/4885HPGD 101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.